{"product_id":"nanomedicine-for-drug-delivery-and-therapeutics-hardback-9781118414095","title":"Nanomedicine for Drug Delivery and Therapeutics (Hardback) 9781118414095","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNanomedicine for Drug Delivery and Therapeutics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eAjay Kumar Mishra (Edited by), AK Mishra (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781118414095, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 12 March 2013\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e536 pages\u003cbr\u003e24.2 x 16.3 x 3.2 cm, 0.875 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThis book describes a broad area of nanomedicine which involves mainly applications, diseases, and diagnostics. The comprehensive coverage provides researchers, academics, and health specialists with a great tool, that includes techniques applicable to various uses.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface xv  \u003cp\u003e\u003cb\u003ePart 1: Nanomedicine 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 High-technology Therapy Using Biomolecules or Synthetic Compounds for HIV Inhibition 3\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eElvis Fosso-Kankeu, Pascaline Fontehand Ajay K.Mishra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Gene Therapy Including RNAHigh-Technology Against HIV 4\u003c\/p\u003e \u003cp\u003e1.2 Metals and HIV Therapy 16\u003c\/p\u003e \u003cp\u003e1.3 Conclusions 26\u003c\/p\u003e \u003cp\u003eReferences 27\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Emerging Nanomedicine Approaches for Osteochondral Tissue Regeneration 39\u003c\/b\u003e\u003cbr\u003e Author Lineis Missing\u003c\/p\u003e \u003cp\u003e2.1 Introduction 39\u003c\/p\u003e \u003cp\u003e2.2 Emerging NanomedicineApproaches 42\u003c\/p\u003e \u003cp\u003eReferences 54\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Synthesis of Poly(Methacrylate) Encapsulated Magnetite Nanoparticles via Phosphonic Acid Anchoring Chemistry and Its Applications Toward Biomedicine 63\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eB. Kothandapaniand Ajay K. Mishra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 64\u003c\/p\u003e \u003cp\u003e3.2 Synthesis of Magnetite Nanoparticles 73\u003c\/p\u003e \u003cp\u003e3.3 Application in Biomedical Fields 82\u003c\/p\u003e \u003cp\u003e3.4 Conclusions 84\u003c\/p\u003e \u003cp\u003eReferences 85\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Potentiometric PVC Membrane Sensors and Their Analytical Applications in Pharmaceuticals and Environmental Samples at Micro- and Nano-level 87\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eGamal Abel-Hafiz Mostafa\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 87\u003c\/p\u003e \u003cp\u003e4.2 Ion Selective Electrode 88\u003c\/p\u003e \u003cp\u003e4.3 Glass Membrane Electrode 89\u003c\/p\u003e \u003cp\u003e4.4 Characteristics of ISE 90\u003c\/p\u003e \u003cp\u003e4.5 Preparation of PVC Membrane 94\u003c\/p\u003e \u003cp\u003e4.6 Method of Preparation of the Liquid Membrane ISEs 96\u003c\/p\u003e \u003cp\u003e4.7 Application of Ion Selective Electrodes in Pharmaceutical and Environmental Analysis Using 97\u003c\/p\u003e \u003cp\u003e4.8 Conclusion 123\u003c\/p\u003e \u003cp\u003eReferences 127\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Bioceramics: Silica-based Organic-Inorganic Hybrid Materials for Medical Applications 135\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSadanand Pandey and Shivani B. Mishra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 136\u003c\/p\u003e \u003cp\u003e5.2 Organic-Inorganic Hybrid Materials 141\u003c\/p\u003e \u003cp\u003e5.3 Tissue Engineering 146\u003c\/p\u003e \u003cp\u003e5.4 Other Organic-Inorganic Bioceramics for Medical Applications 150\u003c\/p\u003e \u003cp\u003e5.5 Conclusion 156\u003c\/p\u003e \u003cp\u003e5.6 Considerations and Future Directions 157\u003c\/p\u003e \u003cp\u003eAcknowledgement 157\u003c\/p\u003e \u003cp\u003eReferences 158\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Recent Advances of Multifunctional Nanomedicines 163\u003c\/b\u003e\u003cbr\u003e \u003ci\u003ePradeep Pratap Singh and Ambika\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 163\u003c\/p\u003e \u003cp\u003e6.2 Nanomaterials of Biomedical Interest 164\u003c\/p\u003e \u003cp\u003e6.3 Target-specificPharmacotherapy: Need for Nanocarrier Delivery Systems 165\u003c\/p\u003e \u003cp\u003e6.4 Engineering of Pharmaceutical Nanosystems 166\u003c\/p\u003e \u003cp\u003e6.5 Applications of Pharmaceutical Nanotools 180\u003c\/p\u003e \u003cp\u003e6.6 Nanotoxicity 181\u003c\/p\u003e \u003cp\u003e6.7 Future prospects 182\u003c\/p\u003e \u003cp\u003e6.8 Conclusion 183\u003c\/p\u003e \u003cp\u003eReferences 184\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Nanomedicinal Approaches for Diabetes Management 189\u003c\/b\u003e\u003cbr\u003e \u003ci\u003ePrashant Kumar Raiand Ajay Kumar Mishra\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction: The Motivation behind the Chapter 189\u003c\/p\u003e \u003cp\u003e7.2 Type of Diabetes 191\u003c\/p\u003e \u003cp\u003e7.3 Treatments for Diabetes 192\u003c\/p\u003e \u003cp\u003e7.4 Why the Interest in Nanomedicine Research? 193\u003c\/p\u003e \u003cp\u003e7.5 The Vision of Nanotechnology and its Clinical Applications for Diabetes 194\u003c\/p\u003e \u003cp\u003e7.6 Summary 195\u003c\/p\u003e \u003cp\u003eAcknowledgements 195\u003c\/p\u003e \u003cp\u003eReferences 195\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Polymeric Nanofibersin Regenerative Medicine 197\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eNarayan Chandra Mishra and Sharmistha Mitra (Majumder)\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 197\u003c\/p\u003e \u003cp\u003e8.2 Preparation of Nanofibers 199\u003c\/p\u003e \u003cp\u003e8.3 RecentAdvances onApplication of Polymeric Nanofibersin Regenerative Medicine 201\u003c\/p\u003e \u003cp\u003e8.4 Conclusions 222\u003c\/p\u003e \u003cp\u003eReferences 222\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart\u003c\/b\u003e \u003cb\u003e2: Drug Delivery and Therapeutics 227\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Multifunctional Nano\/Micro Polymer Capsules as Potential 229\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eHaider Sami, J. Jaishree, Ashok Kumar and Sri Sivakumar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Introduction 230\u003c\/p\u003e \u003cp\u003e9.2 Synthesis of Polymer Capsules 232\u003c\/p\u003e \u003cp\u003e9.3 Properties of Multilayered Polymer Capsules 237\u003c\/p\u003e \u003cp\u003e9.4 Loading of Therapeutics 239\u003c\/p\u003e \u003cp\u003e9.5 Stimuli-responsive Polymer Capsules 242\u003c\/p\u003e \u003cp\u003e9.6 Multifunctional Hybrid Capsules 255\u003c\/p\u003e \u003cp\u003e9.7 Targeted Polymer Capsules 267\u003c\/p\u003e \u003cp\u003e9.8 BiomedicalApplications 268\u003c\/p\u003e \u003cp\u003e9.9 Outlook and Future Prospects 274\u003c\/p\u003e \u003cp\u003eReferences 274\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Nanophosphors-Nanogold Immunoconjugates in Isolation of Biomembranes and in Drug Delivery 285\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eDwijendra Gupta, Dhruv Kumar, Manish Dwivedi, Vijay Tripathi, Pratibha Phadke-Gupta and Surya Pratap Singh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 286\u003c\/p\u003e \u003cp\u003e10.2 Nanoparticle Technology 287\u003c\/p\u003e \u003cp\u003e10.3 The Versatility of Nanoparticles in Biological Sciences 288\u003c\/p\u003e \u003cp\u003e10.4 Materials and Methods 293\u003c\/p\u003e \u003cp\u003e10.5 Nanotags for Bio-labeling and Targeting: Nanophosphors or Quantum Dots 297\u003c\/p\u003e \u003cp\u003e10.6 AFM Study of CdS and BSATagged ZnS-Mn Nanoparticles 302\u003c\/p\u003e \u003cp\u003e10.7 Nano-Conjugates in Drug Delivery 304\u003c\/p\u003e \u003cp\u003e10.8 Nanoparticle-mediated Drug Delivery and Nanotherapeutics 305\u003c\/p\u003e \u003cp\u003e10.9 The Limitations of QDs 306\u003c\/p\u003e \u003cp\u003e10.10 Summary 307\u003c\/p\u003e \u003cp\u003eAcknowledgements 308\u003c\/p\u003e \u003cp\u003eReferences 309\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Cyclodextrin-based Nanoengineered Drug Delivery System 313\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJaya Lakkakula and Rui Werner Maçedo Krause\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 314\u003c\/p\u003e \u003cp\u003e11.2 Inclusion Complex Formation 316\u003c\/p\u003e \u003cp\u003e11.3 Phase Solubility Relationships 318\u003c\/p\u003e \u003cp\u003e11.4 Effect of Cyclodextrin on Drug Formulation 321\u003c\/p\u003e \u003cp\u003e11.5 Cyclodextrin-based Drug Delivery 324\u003c\/p\u003e \u003cp\u003e11.6 Cyclodextrins in Novel Drug Delivery Systems (DDS) 331\u003c\/p\u003e \u003cp\u003e11.7 Conclusion 335\u003c\/p\u003e \u003cp\u003eAcknowledgements 335\u003c\/p\u003e \u003cp\u003eReferences 338\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Medicinal Patches and Drug Nanoencapsulation 343\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMaría H. Lissarrague, Hernan Garate, Melisa E. Lamanna, Norma B. D’Accorso and Silvia N.Goyanes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Introduction 343\u003c\/p\u003e \u003cp\u003e12.2 Overview of Passive Skin Permeation (Passive Patches) 344\u003c\/p\u003e \u003cp\u003e12.3 Recent Development on Skin Permeation 357\u003c\/p\u003e \u003cp\u003e12.4 Drug Encapsulation 361\u003c\/p\u003e \u003cp\u003e12.5 Triggered Release 369\u003c\/p\u003e \u003cp\u003e12.6 Conclusions 374\u003c\/p\u003e \u003cp\u003eReferences 374\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Dendrimers: AClass of Polymer in the Nanotechnology for the Drug Delivery 379\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSunil K.Singh and Vivek K. Sharma\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Introduction 379\u003c\/p\u003e \u003cp\u003e13.2 Historical Origin of Dendrimers 380\u003c\/p\u003e \u003cp\u003e13.3 Structure of Dendrimers 381\u003c\/p\u003e \u003cp\u003e13.4 Terms Used in Dendrimer Chemistry 383\u003c\/p\u003e \u003cp\u003e13.5 Types of Dendrimers 385\u003c\/p\u003e \u003cp\u003e13.6 Application of Dendrimers 392\u003c\/p\u003e \u003cp\u003e13.7 Dendrimers in Oral Drug Delivery 394\u003c\/p\u003e \u003cp\u003e13.8 Dendrimers in Transdermal Drug Delivery 396\u003c\/p\u003e \u003cp\u003e13.9 Dendrimers in Ocular Drug Delivery 398\u003c\/p\u003e \u003cp\u003e13.10 Dendrimers inAnticancer Drug Delivery 399\u003c\/p\u003e \u003cp\u003e13.11 Dendrimers in Cancer Diagnosis and Treatment 401\u003c\/p\u003e \u003cp\u003e13.12 Conclusion 411\u003c\/p\u003e \u003cp\u003eReferences 411\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Designing Nanocarriers for Drug Delivery 417\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMunishwar N. Gupta and Joyeeta Mukherjee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction 417\u003c\/p\u003e \u003cp\u003e14.2 Sizes, Shapes andAdvantages of Nanomaterials 418\u003c\/p\u003e \u003cp\u003e14.3 Bioconjugation Strategies 421\u003c\/p\u003e \u003cp\u003e14.4 Carbon Nanotubes 429\u003c\/p\u003e \u003cp\u003e14.5 Drug Targeting 434\u003c\/p\u003e \u003cp\u003e14.6 Future Perspectives 436\u003c\/p\u003e \u003cp\u003eAcknowledgements 437\u003c\/p\u003e \u003cp\u003eReferences 437\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Multifunctional Polymeric Micelles for Drug Delivery and Therapeutics 443\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eAlicia Sawdon and Ching-An Peng\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15.1 Introduction 443\u003c\/p\u003e \u003cp\u003e15.2 Composition, Formation and Characterization of Polymeric Micelles 444\u003c\/p\u003e \u003cp\u003e15.3 Polymeric Micelles for Cancer Chemotherapy 450\u003c\/p\u003e \u003cp\u003e15.4 Targeting Schemes 457\u003c\/p\u003e \u003cp\u003e15.5 Polymeric Micelles for Diagnostics and Imaging 465\u003c\/p\u003e \u003cp\u003e15.6 Conclusions 467\u003c\/p\u003e \u003cp\u003eReferences 467\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Nanoparticles-based Carriers for Gene Therapy and Drug Delivery 477\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMarketa Ryvolova, Jana Drbohlavova, Kristyna Smerkova, Jana Chomoucka, Pavlina Sobrova,Vojtech Adam, PavelKopel, Jaromir Hubalek and Rene Kizek\u003c\/i\u003e\u003cbr\u003e \u003cbr\u003e 16.1 Introduction 478\u003c\/p\u003e \u003cp\u003e16.2 Targeted Delivery 478\u003c\/p\u003e \u003cp\u003e16.3 Conclusion 494\u003c\/p\u003e \u003cp\u003eReferences 494\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Other branches of medicine [\u003ca title=\"See our other books on Other branches of medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Other%20branches%20of%20medicine%20%5BMM%5D%22\"\u003eMM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley-Scrivener","offers":[{"title":"Brand New","offer_id":52417773502744,"sku":"9781118414095","price":138.47,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9781118414095.jpg?v=1784508038","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/nanomedicine-for-drug-delivery-and-therapeutics-hardback-9781118414095","provider":"Freshly Printed Books","version":"1.0","type":"link"}